Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Stage I Bladder Cancer AJCC v6 and v7”

5 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 5 of 5 results

Testing effectiveness (Phase 2)Active Not RecruitingNCT00365157
What this trial is testing

Eribulin Mesylate in Treating Patients With Locally Advanced or Metastatic Cancer of the Urothelium and Kidney Dysfunction

Who this might be right for
Advanced Urothelial CarcinomaLocally Advanced Urothelial CarcinomaMetastatic Urothelial Carcinoma+4 more
National Cancer Institute (NCI) 132
Testing effectiveness (Phase 2)Study completedNCT02844816
What this trial is testing

Atezolizumab in Treating Patients With Recurrent BCG-Unresponsive Non-muscle Invasive Bladder Cancer

Who this might be right for
Recurrent Bladder Urothelial CarcinomaStage 0a Bladder Urothelial Carcinoma AJCC v6 and v7Stage 0is Bladder Urothelial Carcinoma AJCC v6 and v7+1 more
National Cancer Institute (NCI) 172
Testing effectiveness (Phase 2)Study completedNCT00118040
What this trial is testing

Phase II Study of Isoflavone G-2535 (Genistein) in Patients With Bladder Cancer

Who this might be right for
Recurrent Bladder CarcinomaStage I Bladder Cancer AJCC v6 and v7Stage II Bladder Cancer AJCC v6 and v7+1 more
National Cancer Institute (NCI) 60
Not applicableLooking for participantsNCT05334069
What this trial is testing

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

Who this might be right for
Acute Lymphoblastic LeukemiaAcute Myeloid LeukemiaAnn Arbor Stage I Lymphoma+59 more
Alliance for Clinical Trials in Oncology 2,000
Testing effectiveness (Phase 2)Study completedNCT00238420
What this trial is testing

Paclitaxel and Radiation Therapy With or Without Trastuzumab in Treating Patients Who Have Undergone Surgery for Bladder Cancer

Who this might be right for
Bladder Urothelial CarcinomaStage I Bladder Cancer AJCC v6 and v7Stage II Bladder Cancer AJCC v6 and v7+1 more
National Cancer Institute (NCI) 70